BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7233888)

  • 1. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals.
    Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH
    Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of specific anti-HBO immunoglobulin of IgM or IgG type. Relation to other virus HB markers].
    Maniez-Montreuil M; Dupressoir-Burlet MV; Goudemand M
    Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):245-63. PubMed ID: 7111979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
    Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
    J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
    J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive.
    Gussetti N; Pornaro E; Largajolli G; D'Elia R
    Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen.
    Stephan W; Prince AM; Brotman B
    J Virol; 1984 Aug; 51(2):420-4. PubMed ID: 6748163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies.
    Colucci G; Beazer Y; Cantaluppi C; Tackney C
    J Immunol; 1988 Dec; 141(12):4376-80. PubMed ID: 2461991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection.
    Thomas HI
    J Med Virol; 1997 Mar; 51(3):189-97. PubMed ID: 9139082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.
    Sällberg M; Norder H; Magnius LO
    J Med Virol; 1990 Jan; 30(1):1-6. PubMed ID: 2303802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing between acute and symptomatic chronic hepatitis B virus infection.
    Maruyama T; Schödel F; Iino S; Koike K; Yasuda K; Peterson D; Milich DR
    Gastroenterology; 1994 Apr; 106(4):1006-15. PubMed ID: 7511551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAg carrier infants with serum anti-HBc negativity.
    Lee SD; Lo KJ; Tsai YT; Wu JC; Wu TC
    Hepatology; 1989 Jan; 9(1):102-4. PubMed ID: 2521178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM.
    Hwang LY; Roggendorf M; Beasley RP; Deinhardt F
    J Med Virol; 1985 Mar; 15(3):265-9. PubMed ID: 3981147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of hepatitis B e antigen (HBeAg) and anti-HBe in carriers with different levels of HBsAg.
    Nath N; Fang CT; Fields HA; Doto IL; Maynard JE
    J Med Virol; 1980; 6(2):179-84. PubMed ID: 7241093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the relationship between the prognosis of chronic active hepatitis and the HBV associated antigen/antibody systems.
    Kosaka Y; Tameda Y; Okuda Y; Takase K; Sawa H; Takezawa H
    Gastroenterol Jpn; 1981 Dec; 16(6):592-9. PubMed ID: 7333448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune recognition of linear antigenic regions within the hepatitis B pre-C and C-gene translation products using synthetic peptides.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    J Med Virol; 1994 Jan; 42(1):7-15. PubMed ID: 7508491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.